
This document is meant to assist national HIV programs in pDTG adoption. This document provides a summary of pDTG, including advantages over other ARVs, cost, dosing, administration, side effects, and transition considerations.
A framework to support new product introduction in national health systems
Updated: Jan 13, 2022
This document is meant to assist national HIV programs in pDTG adoption. This document provides a summary of pDTG, including advantages over other ARVs, cost, dosing, administration, side effects, and transition considerations.